Hollencrest Capital Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.1K | Hold |
516
| – | – | ﹤0.01% | 561 |
|
|
2025
Q1 | $32.8K | Hold |
516
| – | – | ﹤0.01% | 559 |
|
|
2024
Q4 | $34.4K | Hold |
516
| – | – | ﹤0.01% | 563 |
|
|
2024
Q3 | $36.1K | Hold |
516
| – | – | ﹤0.01% | 553 |
|
|
2024
Q2 | $33.5K | Hold |
516
| – | – | ﹤0.01% | 556 |
|
|
2024
Q1 | $33.4K | Hold |
516
| – | – | ﹤0.01% | 548 |
|
|
2023
Q4 | $34K | Hold |
516
| – | – | ﹤0.01% | 542 |
|
|
2023
Q3 | $29.5K | Hold |
516
| – | – | ﹤0.01% | 556 |
|
|
2023
Q2 | $31.6K | Hold |
516
| – | – | ﹤0.01% | 560 |
|
|
2023
Q1 | $32.4K | Hold |
516
| – | – | ﹤0.01% | 551 |
|
|
2022
Q4 | $32.8K | Buy |
+516
| New | +$32.8K | ﹤0.01% | 528 |
|